0

No products in the cart.

0

No products in the cart.

Home Business ‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
Business

‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

Updated 1 day Ago1 Mins read3 Views
Share
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
Share


The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.

Source link

Share
Apple launches a new Apple TV 4K with Siri AI and remote-free voice commands Previous post Apple launches a new Apple TV 4K with Siri AI and remote-free voice commands

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Did this year’s COLA beat inflation? Here’s how spending by American seniors stacks up so far in 2026.
Business

Did this year’s COLA beat inflation? Here’s how spending by American seniors stacks up so far in 2026.

3 minutes Ago
Why is Wolfspeed stock sliding today?
Business

Why is Wolfspeed stock sliding today?

8 minutes Ago
CeriBell Inc stock hits 52-week high at 26.66 USD
Business

CeriBell Inc stock hits 52-week high at 26.66 USD

18 minutes Ago
Top biotechnology stock pick from Guggenheim
Business

Top biotechnology stock pick from Guggenheim

29 minutes Ago

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved

    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com